Bioimpedance in CKD: an untapped resource?

Ítems similars

• Bioimpedance indices of fluid overload and cardiorenal outcomes in heart failure and chronic kidney disease: a systematic review
  per: Mayne, KJ, et al.
  Publicat: (2022)
• In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes
  per: Mayne, KJ, et al.
  Publicat: (2022)
• Impact of primary kidney disease on the effects of empagliflozin in patients with CKD
  per: Judge, PK, et al.
  Publicat: (2023)
• In HF, T2D, CKD, or atherosclerotic CVD, SGLT2 inhibitors reduce HF hospitalizations and CV mortality
  per: Zhu, D, et al.
  Publicat: (2024)
• Effects of sodium-glucose cotransporter 2 inhibitors on cause-specific cardiovascular death in patients with CKD
  per: Fletcher, RA, et al.
  Publicat: (2024)